52 results
8-K
EX-10.1
NEO
Neogenomics Inc.
21 Jul 22
NeoGenomics Announces Chief Executive Officer Appointment
4:41pm
, administrative fees, court costs, and all expenses, including, without limitation, all fees, taxes, costs and expenses incident to post-judgment proceedings
8-K
EX-1.2
NEO
Neogenomics Inc.
11 Jan 21
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:13pm
to be paid all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, printing and filing … with the road show, (x) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in connection
8-K
EX-1.1
NEO
Neogenomics Inc.
11 Jan 21
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:13pm
.
(a)Expenses. The Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including (i … with the road show, (viii) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in connection with, the review
8-K
EX-1.2
NEO
Neogenomics Inc.
4 May 20
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:18pm
incident to the performance of its obligations under this Agreement, including (i) the preparation, printing and filing of the Registration Statement … , (x) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in connection with, the review by FINRA
8-K
EX-1.1
rc5tnjw9k
4 May 20
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:18pm
8-K
EX-2.1
jdth1my6f1ew 7sig
13 Jan 20
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
4:50pm
8-K
EX-10.1
tz3yyncd3
2 Dec 19
Departure of Directors or Certain Officers
5:07pm
8-K
EX-10.3
nug718g406mxiiiz
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-1.1
qbxjd
22 May 19
NeoGenomics Announces Pricing on Public Offering of Common Stock
8:15am
8-K
EX-1.1
v291xb1cn3e9ubd4p
12 Dec 18
NeoGenomics Announces Pricing on Secondary Offering of
4:18pm
8-K
EX-2.1
z1lvt9unjd06x8
26 Oct 18
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-1.1
lvisd0
10 Aug 18
NeoGenomics Announces Pricing on Public Offering of Common Stock
10:29am
8-K
EX-10.1
e7kvf 06vifyrgat54
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
p2ja0h6ixptr4 q1
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
boibz26w 0zef7v7w
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
p7x2xu5vo6rbe
26 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
92kn wp032bqst26hg4x
26 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
0e6bdddpto42ju
15 Aug 14
NeoGenomics Announces Pricing of $32.2 Million Public Offering
12:00am